Publications by authors named "David Semel"

Claim this Profile
E
Efficacy and safety of rimegepant 75 mg for acute treatment of migraine: a pooled analysis of four randomized, placebo-controlled trials.
Stewart J Tepper, Jelena M Pavlovic, Shengyuan Yu, Richard B Lipton, Glenn Pixton, David Semel

Postgrad Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A practical guide to recognize, assess, treat and evaluate (RATE) primary care patients with chronic pain.
Kevin B Gebke, Bill McCarberg, Erik Shaw, Dennis C Turk, Wendy L Wright, David Semel

Postgrad Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the Relationships Among Treatment, Pain, and Physical Function in Patients With Osteoarthritis: A Mediation-Modeling Approach.
Lucy Abraham, Robert H Dworkin, Dennis C Turk, John D Markman, David A Williams, David C Semel

Clin J Pain· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gender, age, disease severity, body mass index and diabetes may not affect response to subcutaneous tanezumab in patients with osteoarthritis after 16 weeks of treatment. A subgroup analysis of placebo-controlled trials.
Francis Berenbaum, Thomas Schnitzer, Alan Kivitz, Lars Viktrup, Elizabeth Johnston, David Semel

Int J Clin Pract· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities across Diverse Populations in the Health and Treatment of Patients with Osteoarthritis.
Warachal E Faison, P Grace Harrell, David Semel

Healthcare (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evidence-based review of pregabalin for the treatment of fibromyalgia.
Lesley M Arnold, Ernest Choy, Daniel J Clauw, Hiroshi Oka, Ed Whalen, David Semel

Curr Med Res Opin· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalizing fibromyalgia as a chronic illness.
Daniel J Clauw, Yvonne D'Arcy, Kevin Gebke, David Semel, Lynne Pauer

Postgrad Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials.
John D Markman, Troels Staehelin Jensen, David Semel, Chunming Li, Bruce Parsons

Pain Pract· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and Work Loss Burden of Diagnosed Opioid Abuse Among Employees on Workers Compensation or Short-term Disability.
Stephen S Johnston, Andrea H Alexander, Elizabeth T Masters, Jack Mardekian, David Semel

J Occup Environ Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
David M Simpson, Andrew S C Rice, Birol Emir, Jaren Landen, David Semel

Pain· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies.
David Semel, T Kevin Murphy, Gergana Zlateva, Raymond Cheung, Birol Emir

BMC Fam Pract· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis